Author:
Derwahl K.-M.,Dietlein M.,Dralle H.,Farahati J.,Feldkamp J.,Frilling A.,Heufelder A.,Machens A.,Mann K.,Reiners C.,Rüschoff J.,Saller B.,Scherbaum W. A.,Schicha H.,Schulte K.-M.,Röher H.-D.,Gerharz C. D.,Joseph K.,Rothmund M.,Zielke A.,Gimm O.,Goretzki P.,Dotzenrath C.,Hüfner M.,Schumm-Draeger P.-M.,Spitzweg C.
Publisher
Springer Berlin Heidelberg
Reference648 articles.
1. Aeschimann S, Kopp PA, Kimura ET et al. (1993) Morphological and functional polymorphism within clonal thyroid nodules. J Clin Endocrinol Metab 77: 846–851
2. Ajjan RA, Findlay C, Metcalfe RA et al. (1998) The modulation of the human sodium iodide symporter activity by Graves’ disease sera. J Clin Endocrinol Metab 83: 1217–1221
3. Badenhoop K, Donner H, Braun J et al. (1997) Genetic markers in diagnosis and prediction of relapse in Graves’ disease. Exp Clin Endocrinol Diabetes 104 (suppl 4): 98–100
4. Cavalieri RR (1997) Iodine metabolism and thyroid physiology: current concepts. Thyroid 7: 177–181
5. Clark OH (1996) Predictors of thyroid tumor aggressiveness. West J Med 165: 131–138